
Marivelisse Santiago Cordero
Supervisory Patent Examiner (ID: 14190, Phone: (571)272-7839 , Office: P/2676 )
| Most Active Art Unit | 2617 |
| Art Unit(s) | 2617, 2676, 2687, 3700, 2625 |
| Total Applications | 313 |
| Issued Applications | 159 |
| Pending Applications | 12 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18107853
[patent_doc_number] => 20230000733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => PREPARATION METHOD AND APPLICATION OF SINGLE EMULSIFIER AND DOUBLE EMULSION BASED ON DNA TRIANGULAR ORIGAMI TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/752477
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752477 | Preparation method and application of single emulsifier and double emulsion based on DNA triangular origami technology | May 23, 2022 | Issued |
Array
(
[id] => 19172834
[patent_doc_number] => 20240158808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => GENE THERAPY FOR DENT DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/289875
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289875
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289875 | GENE THERAPY FOR DENT DISEASE | May 19, 2022 | Pending |
Array
(
[id] => 19345550
[patent_doc_number] => 20240254513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => VIRAL VECTOR PRODUCTION SYSTEMS, ENGINEERED CELLS FOR VIRAL VECTOR PRODUCTION, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/561050
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561050 | VIRAL VECTOR PRODUCTION SYSTEMS, ENGINEERED CELLS FOR VIRAL VECTOR PRODUCTION, AND METHODS OF USE THEREOF | May 16, 2022 | Pending |
Array
(
[id] => 19541821
[patent_doc_number] => 20240358857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY AND COMBINATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/559078
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559078
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559078 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY AND COMBINATIONS THEREOF | May 10, 2022 | Pending |
Array
(
[id] => 19280069
[patent_doc_number] => 20240216542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => GM3 SYNTHASE VECTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/557102
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557102
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/557102 | GM3 SYNTHASE VECTORS AND USES THEREOF | Apr 17, 2022 | Pending |
Array
(
[id] => 19188078
[patent_doc_number] => 20240166991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => CELL CULTURE MEDIUM COMPOSITION CONTAINING SPIRULINA HYDROLYSATE, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/551128
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551128
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551128 | CELL CULTURE MEDIUM COMPOSITION CONTAINING SPIRULINA HYDROLYSATE, AND PREPARATION METHOD THEREFOR | Mar 31, 2022 | Pending |
Array
(
[id] => 20179780
[patent_doc_number] => 20250263738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/285000
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18285000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/285000 | MODIFIED VIRUSES AND VIRAL PARTICLES, METHODS OF MAKING, AND USES THEREOF | Mar 31, 2022 | Pending |
Array
(
[id] => 17930177
[patent_doc_number] => 20220325302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/656562
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656562 | ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR RESTORING PAH GENE FUNCTION AND METHODS OF USE THEREOF | Mar 24, 2022 | Abandoned |
Array
(
[id] => 19218212
[patent_doc_number] => 20240182916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/551562
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551562
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551562 | RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE | Mar 24, 2022 | Pending |
Array
(
[id] => 20207514
[patent_doc_number] => 20250277234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => RECOMBINANT CHIMERIC ADENOVIRAL VECTOR SUBSTITUTED BY KNOB GENE OF CHIMPANZEE ADENOVIRUS SEROTYPE 6, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/551261
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551261
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551261 | RECOMBINANT CHIMERIC ADENOVIRAL VECTOR SUBSTITUTED BY KNOB GENE OF CHIMPANZEE ADENOVIRUS SEROTYPE 6, AND APPLICATION THEREOF | Mar 23, 2022 | Pending |
Array
(
[id] => 19218217
[patent_doc_number] => 20240182921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 18/279434
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279434
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279434 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOPHILIA | Mar 3, 2022 | Pending |
Array
(
[id] => 19172776
[patent_doc_number] => 20240158750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/279336
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -109
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279336
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279336 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | Mar 3, 2022 | Pending |
Array
(
[id] => 18194498
[patent_doc_number] => 20230048017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/685457
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685457 | ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF | Mar 2, 2022 | Pending |
Array
(
[id] => 18988058
[patent_doc_number] => 20240060027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => CELL CULTURE SCAFFOLD FORMED VIA 3D PRINTING
[patent_app_type] => utility
[patent_app_number] => 18/278886
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278886
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278886 | CELL CULTURE SCAFFOLD FORMED VIA 3D PRINTING | Feb 17, 2022 | Pending |
Array
(
[id] => 17828437
[patent_doc_number] => 20220265741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties
[patent_app_type] => utility
[patent_app_number] => 17/670789
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670789 | Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties | Feb 13, 2022 | Pending |
Array
(
[id] => 18955468
[patent_doc_number] => 20240043795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => NUTRIENT MEDIA FOR CELL CULTURE CONTAINING PLANT PROTEIN HYDROLYSATES
[patent_app_type] => utility
[patent_app_number] => 18/276886
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276886
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276886 | NUTRIENT MEDIA FOR CELL CULTURE CONTAINING PLANT PROTEIN HYDROLYSATES | Feb 8, 2022 | Pending |
Array
(
[id] => 19464472
[patent_doc_number] => 20240318141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => MATURATION AGENT
[patent_app_type] => utility
[patent_app_number] => 18/273441
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273441
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273441 | MATURATION AGENT | Feb 8, 2022 | Pending |
Array
(
[id] => 19594404
[patent_doc_number] => 12152234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Method of screening CO2-assimilating microorganism
[patent_app_type] => utility
[patent_app_number] => 17/586587
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5071
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586587 | Method of screening CO2-assimilating microorganism | Jan 26, 2022 | Issued |
Array
(
[id] => 19081187
[patent_doc_number] => 20240107988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => DOWN-REGULATION OF ENDOGENOUS GENES
[patent_app_type] => utility
[patent_app_number] => 18/262018
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262018 | DOWN-REGULATION OF ENDOGENOUS GENES | Jan 26, 2022 | Pending |
Array
(
[id] => 19049297
[patent_doc_number] => 20240091266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => OPIOID SPARING COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/262505
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262505 | OPIOID SPARING COMPOSITIONS AND METHODS OF USING THE SAME | Jan 20, 2022 | Pending |